Competitive problems in the pharmaceutical drug industry hearing before the Subcommittee on Antitrust, Monopolies [sic], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session, on the generic drug industry and its concerns with respect to competition from the brand name manufacturers, October 21, 1987.

Saved in:
Bibliographic Details
Corporate author / creator:United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopoly, and Business Rights.
Imprint:Washington : U.S. G.P.O., 1989.
Description:iv, 234 p. : ill., forms ;
Language:English
Series:S. hrg. ; 100-922
United States. Congress. Senate. S. hrg. ; 100-922.
Subject:
Format: E-Resource U.S. Federal Government Document Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/10699760
Related Items:Print version: Competitive problems in the pharmaceutical drug industry
Hidden Bibliographic Details
Other uniform titles:ProQuest U.S. Congressional Hearings Digital Collection.
Notes:Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
Includes bibliographies.
Electronic reproduction. [Bethesda, Md.] : ProQuest, 2004. digital, PDF file. ProQuest U.S. Congressional Hearings Digital Collection. Mode of access: World Wide Web via ProQuest website.
Other form:Print version: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopoly, and Business Rights. Competitive problems in the pharmaceutical drug industry
Microfiche version: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopoly, and Business Rights. Competitive problems in the pharmaceutical drug industry. [Bethesda, Md.] : ProQuest,[2004] CIS 89 S521-9
GPO item no.:1042-A, 1042-B (microfiche)
Govt.docs classification:Y 4.J 89/2:S.hrg.100-922